Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Oncotarget
|
February 22, 2018
SNP-array lesions in core binding factor acute myeloid leukemia
Nicolas Duployez, Elise Boudry-Labis, Christophe Roumier, et al.
JAMA Oncology
|
July 17, 2015
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial
Animesh Pardanani, Claire Harrison, Jorge E Cortes, et al.
Annals of Hematology
|
January 25, 2024
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study
Ludovic Gabellier, Pierre Peterlin, Sylvain Thepot, et al.
Blood
|
March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Nicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
Haematologica
|
October 19, 2010
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
Nicola Gökbuget, Christina-Maria Hartog, Renato Bassan, et al.
Haematologica
|
February 26, 2015
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial
Nicolas Boissel, Aline Renneville, Thibaut Leguay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS
Arnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
European Journal of Haematology
|
March 18, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status
Claire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, et al.
The New England Journal of Medicine
|
December 24, 2010
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia
Claude Preudhomme, Joëlle Guilhot, Franck Emmanuel Nicolini, et al.
Blood
|
January 17, 2013
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
Eric Jourdan, Nicolas Boissel, Sylvie Chevret, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Oncotarget
|
February 22, 2018
SNP-array lesions in core binding factor acute myeloid leukemia
Nicolas Duployez, Elise Boudry-Labis, Christophe Roumier, et al.
JAMA Oncology
|
July 17, 2015
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial
Animesh Pardanani, Claire Harrison, Jorge E Cortes, et al.
Annals of Hematology
|
January 25, 2024
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study
Ludovic Gabellier, Pierre Peterlin, Sylvain Thepot, et al.
Blood
|
March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Nicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
Haematologica
|
October 19, 2010
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
Nicola Gökbuget, Christina-Maria Hartog, Renato Bassan, et al.
Haematologica
|
February 26, 2015
Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial
Nicolas Boissel, Aline Renneville, Thibaut Leguay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 19, 2010
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS
Arnaud Pigneux, Jean-Luc Harousseau, Francis Witz, et al.
European Journal of Haematology
|
March 18, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status
Claire Jouzier, Jean-François Hamel, Pierre-Yves Dumas, et al.
The New England Journal of Medicine
|
December 24, 2010
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia
Claude Preudhomme, Joëlle Guilhot, Franck Emmanuel Nicolini, et al.
Blood
|
January 17, 2013
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
Eric Jourdan, Nicolas Boissel, Sylvie Chevret, et al.
Page
of 9